Lisata Therapeutics annual gross margin
2010
2011
2012
2013
2014
2015
2016
Lisata Therapeutics Gross Margin Growth & History (LSTA)
Lisata Therapeutics's gross margin was 11.76% for fiscal 2016.
View full Lisata Therapeutics company overviewLisata Therapeutics annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2016 | 2016-12-31 | 11.76% | +1.40 pp |
| 2015 | 2015-12-31 | 10.36% | −2.24 pp |
| 2014 | 2014-12-31 | 12.60% | +0.87 pp |
| 2013 | 2013-12-31 | 11.73% | −4.88 pp |
| 2012 | 2012-12-31 | 16.61% | +2.65 pp |
| 2011 | 2011-12-31 | 13.96% | −14.90 pp |
| 2010 | 2010-12-31 | 28.86% | — |
Lisata Therapeutics quarterly gross margin
Q2.10
Q3.10
Q1.11
Q2.11
Q3.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q1 2017 | 2017-03-31 | −1.51% | −18.35 pp |
| Q4 2016 | 2016-12-31 | 9.15% | −9.06 pp |
| Q3 2016 | 2016-09-30 | 7.58% | −10.76 pp |
| Q2 2016 | 2016-06-30 | 15.05% | +13.88 pp |
| Q1 2016 | 2016-03-31 | 16.84% | +23.03 pp |
| Q4 2015 | 2015-12-31 | 18.22% | −2.87 pp |
| Q3 2015 | 2015-09-30 | 18.34% | +15.77 pp |
| Q2 2015 | 2015-06-30 | 1.16% | −16.92 pp |
| Q1 2015 | 2015-03-31 | −6.19% | −11.87 pp |
| Q4 2014 | 2014-12-31 | 21.09% | +3.09 pp |
| Q3 2014 | 2014-09-30 | 2.57% | −17.15 pp |
| Q2 2014 | 2014-06-30 | 18.08% | +15.23 pp |
| Q1 2014 | 2014-03-31 | 5.68% | +0.46 pp |
| Q4 2013 | 2013-12-31 | 18.00% | +9.23 pp |
| Q3 2013 | 2013-09-30 | 19.72% | +4.24 pp |
| Q2 2013 | 2013-06-30 | 2.85% | −16.01 pp |
| Q1 2013 | 2013-03-31 | 5.22% | −16.43 pp |
| Q4 2012 | 2012-12-31 | 8.77% | — |
| Q3 2012 | 2012-09-30 | 15.48% | +2.36 pp |
| Q2 2012 | 2012-06-30 | 18.86% | −0.14 pp |
| Q1 2012 | 2012-03-31 | 21.66% | −5.47 pp |
| Q3 2011 | 2011-09-30 | 13.12% | −18.70 pp |
| Q2 2011 | 2011-06-30 | 19.00% | −14.47 pp |
| Q1 2011 | 2011-03-31 | 27.13% | — |
| Q3 2010 | 2010-09-30 | 31.82% | — |
| Q2 2010 | 2010-06-30 | 33.47% | — |
Lisata Therapeutics gross margin trends
Over the last five fiscal years, Lisata Therapeutics's gross margin decreased from 13.96% to 11.76%, a change of −2.21 percentage points. The latest reported quarter, Q1 2017, shows −1.51%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Lisata Therapeutics source filings ↗Community posts
Lisata acquires Marea and signs $225 million financing agreement
Lisata ($LSTA) Therapeutics acquired Marea Therapeutics in a stock-for-stock transaction and signed a concurrent agreement for approximately $225 million in gross private-placement proceeds. The financing involves non-voting convertible pre ...
